Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Massachusetts Institute of Technology, Cambridge, Massachusetts

Key details

Sponsor

Massachusetts Institute of Technology

Enrollment target

~60 participants

Started

December 2022

Primary completion

September 2026

Age range

65 Years – 100 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.